MAHWAH, N.J., Feb 23, 2011 /PRNewswire-Asia-FirstCall/ --
Mindray Medical International Limited (NYSE: MR), a leading
developer, manufacturer and marketer of medical devices worldwide,
today announced that its A5 Anesthesia System has received 510(k)
clearance from the U.S. Food and Drug Administration (FDA). The A5
anesthesia device, part of the all new A Series portfolio, is an
anesthesia delivery platform that will complement Mindray's broad
range of existing ultrasound and patient monitoring systems.
(Photo: http://photos.prnewswire.com/prnh/20110223/CN53658)
The A5's intuitive user interface and ergonomic design simplify
workflows. Meanwhile, its 15" touch screen enables clinicians to
quickly and easily select ventilation settings, so less time is
spent maneuvering and more time is devoted to patient care. The
ample work surface, central brake and integrated cable sweeps
enhance effectiveness and device mobility.
A5 is the first and only anesthesia machine that conforms to the
IHE (Integrating the Healthcare Enterprise) Patient Care Domain
(PCD) profile. At no additional charge, every A5 provides data
output in the industry standard HL7 protocol. HL7, with the IHE PCD
profile, is recognized among anesthesia information management
systems (AIMS) and electronic medical records (EMR) systems as the
demonstrated industry standard for unambiguous
interoperability.
The A5 provides a range of advanced ventilation modes enabling
effective care across different patient acuity types. Integrated
spirometry offers additional information which enhances careful
decision making.
The unique, auxiliary O2/Air Blender reduces the risk of
surgical fires by controlling the oxygen concentration under the
drape, near the patient's head and chest.
"The A5 Anesthesia System is simple to use and well designed
with the most intuitive user interface in the business," said
Thomas Barford, Vice President of
Anesthesia Systems at Mindray North America. "We are confident that
the A5 will be very competitive and well-received in the
marketplace."
"The A5 is the first of our new series of anesthesia machines
that bring advanced design features to the Mindray portfolio. By
creating a highly differentiated product that includes more
standard ventilation features, we are significantly expanding our
ability to serve the US hospital market," said David Gibson, President, Mindray North
America.
About Mindray
We are a leading developer, manufacturer and marketer of medical
devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in
Mahwah, New Jersey and multiple
sales offices in major international markets. From our main
manufacturing and engineering base in China and through our worldwide distribution
network, we are able to supply internationally a broad range of
products across three primary business segments, comprised of
patient monitoring and life support products, in-vitro diagnostic
products and medical imaging systems. For more information, please
visit http://www.mindray.com.
Press Release A5 510(k) Clearance part number 0002-08-1394
For investor and media
inquiries, please contact:
|
|
|
|
In the U.S.:
|
|
|
|
Hoki Luk
|
|
|
|
Western Bridge,
LLC
|
|
|
|
Tel:
+1-646-808-9150
|
|
|
|
Email:
hoki.luk@westernbridgegroup.com
|
|
|
|
|
|
In China:
|
|
|
|
Cathy Gao
|
|
|
|
Mindray Medical
International Limited
|
|
|
|
Tel:
+86-755-2658-2620
|
|
|
|
Email:
cathy.gao@mindray.com
|
|
|
SOURCE Mindray Medical International Limited